Generic Name : Rotavirus Vaccine Pronunciation : ROE-ta-vye-rus VAX-een, lyve Therapeutic Classification : Immunizing Agents ICD Code : Y59.0♦ Safety Labeling Changes Approved By FDA
International- Rotarix, RotaTeq. Why it is prescribed (Indications) :
This medication is a vaccine, prescribed for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types in infants and children. It helps the immune system to protect against rotavirus. When it is not to be taken (Contraindications): Contraindicated in patients with uncorrected congenital malformation of the gastrointestinal tract.
Dosage & When it is to be taken :
The vaccination series consists of two 1-mL doses administered orally. The first dose should be administered to infants beginning at 6 weeks of age. There should be an interval of at least 4 weeks between the first and second dose. The 2-dose series should be completed by 24 weeks of age. How it should be taken :
It comes as a solution to take by mouth. Warnings and Precautions :
* Caution should be exercised in patients with history of gastrointestinal disorders, poor immunity and any allergy.
* The healthcare provider should inform the parents or guardians about the possible adverse reactions.
Side Effects :
Most Common- Fussiness, irritability, cough, runny nose, fever, vomiting and diarrhea.
Serious- Death and intestinal blockage.
Blood and Lymphatic- Decrease in platelets and bruising.
♦ Gastrointestinal- Blood in the stools and intussusception.
*Avoid excess dosage. Storage Conditions :
Vial- Store it in refrigerator (2° to 8°C).
Diluent- The diluent may be stored at a controlled room temperature 20° to 25°C. Do not freeze. Discard if the diluent has been frozen.
Comment & Contribute
Ask an Expert